# Innoviva, Inc. (INVA): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Innoviva, Inc. (INVA) is 93/100, ranked against 24,000+ stocks in 35 markets (Quality 74, Value 78, Momentum 45, each scored against its sector).

- StockRank: 93/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 74, Value 78, Momentum 45: each a 0-100 percentile within the stock's sector.
- Position: #1,790 overall, #199 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 21.45 USD on 12 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.
- Buybacks, last 180 days: the company bought back USD 51.3M on 2 days.

Source: https://moatmap.ai/stock/INVA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker